Discussing hospitals’ financial state of affairs: The picture the American Hospital Association paints differs from other industry sources. We explore both sides.

Apple’s hearing study explores the prevalence of tinnitus: And we explore Apple’s motivations for the study, as a leader in the personal audio device market.

Waystar plans $1 billion IPO: Here’s why the timing of the healthcare payment company’s IPO is significant and who we expect to receive the lion’s share of digital health funding for the foreseeable future.

Dollar General shuts down mobile clinic pilot: It’s just the latest retailer to pull out of health clinics. Here’s what fewer health clinics mean for rural US residents’ health outcomes.

Why healthcare providers must build trust with patients: Understanding the drivers of patient retention is arguably more important for PCPs than acquiring new patients. Here’s why.

Yale study reveals ChatGPT shows racial bias: Medical racism in the US could infiltrate AI-powered tools designed to help patients.

Affordable healthcare is top-of-mind for adults over 50: Older consumers’ concerns about healthcare costs dovetail with their concerns about the future of Social Security and Medicare.

Express Scripts partners with independent pharmacies: We examine the possible motivations behind PBMs’ recent efforts to support smaller pharmacies.

GLP-1s effectively combat kidney disease: A new study highlights Ozempic and Wegovy’s promise in the renal space. We address the prescription drug spending elephant in the room.

Consumers trust pharmacists to provide medical services: But barriers prevent pharmacists from having an expanded role in patient care.

Most patients quit GLP-1 weight loss drugs before seeing benefits: Here’s the reality for patients taking GLP-1s for weight loss and the unique opportunity it presents for pharma marketers.

BCW rolls out health influencer marketing service: The agency’s launch comes while consumers are highly engaged with health content on social media.

Hims & Hers offers compounded GLP-1 weight loss drugs: Will offering non-FDA-approved GLP-1s be worth the risk for Hims? We think so.

Health systems are carefully evaluating genAI documentation solutions: But the market is quickly crowding with new tools. Price and product differentiation will be paramount.

FDA’s drug advertising transparency rule takes hold: Here’s how it impacts pharma and which advertisers will see the most success reaching and converting patients.

Patients with health conditions want to learn about their medication options: We explore how pharma brands and marketers can better position themselves as patient educators.

Uber steers into the caregiver space: Uber’s newest feature could help patients and insurers alike. But there are a few factors that could prevent Uber Caregiver from reaching its full potential.

Healthcare leaders applaud Ascension’s cyberattack response: A healthcare organization’s reaction to a cyberattack can make all the difference when it comes to reputation.

GoodRx inks direct contracting agreement with Kroger: Investors should be happy with GoodRx’s redefined approach to drug pricing and pharma partnerships.

LG bets on home healthcare: But the company may struggle to capture market share from entrenched home health rivals like Best Buy Health and Samsung.